Northern Trust’s Atossa Therapeutics ATOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $101K | Sell |
19,224
-3
| -0% | -$19 | ﹤0.01% | 4106 |
|
|
2025
Q4 | $170K | Buy |
19,227
+1,669
| +10% | +$21.1K | ﹤0.01% | 4031 |
|
|
2025
Q3 | $228K | Hold |
17,558
| – | – | ﹤0.01% | 3937 |
|
|
2025
Q2 | $219K | Sell |
17,558
-47,375
| -73% | -$566K | ﹤0.01% | 3910 |
|
|
2025
Q1 | $655K | Sell |
64,933
-3,449
| -5% | -$41.9K | ﹤0.01% | 3465 |
|
|
2024
Q4 | $968K | Buy |
68,382
+4,769
| +7% | +$93.1K | ﹤0.01% | 3409 |
|
|
2024
Q3 | $1.45M | Buy |
63,613
+45,799
| +257% | +$925K | ﹤0.01% | 3178 |
|
|
2024
Q2 | $318K | Buy |
17,814
+2,769
| +18% | +$61.3K | ﹤0.01% | 3676 |
|
|
2024
Q1 | $406K | Sell |
15,045
-150
| -1% | -$2.41K | ﹤0.01% | 3631 |
|
|
2023
Q4 | $201K | Buy |
15,195
+886
| +6% | +$9.56K | ﹤0.01% | 3898 |
|
|
2023
Q3 | $158K | Hold |
14,309
| – | – | ﹤0.01% | 3893 |
|
|
2023
Q2 | $270K | Sell |
14,309
-56
| -0.4% | -$679 | ﹤0.01% | 3709 |
|
|
2023
Q1 | $156K | Sell |
14,365
-318
| -2% | -$3.55K | ﹤0.01% | 3943 |
|
|
2022
Q4 | $116K | Hold |
14,683
| – | – | ﹤0.01% | 4044 |
|
|
2022
Q3 | $183K | Buy |
14,683
+86
| +0.6% | +$1.25K | ﹤0.01% | 3908 |
|
|
2022
Q2 | $239K | Sell |
14,597
-52,533
| -78% | -$828K | ﹤0.01% | 3829 |
|
|
2022
Q1 | $1.26M | Sell |
67,130
-2,836
| -4% | -$57.6K | ﹤0.01% | 3317 |
|
|
2021
Q4 | $1.68M | Sell |
69,966
-2,202
| -3% | -$80.6K | ﹤0.01% | 3312 |
|
|
2021
Q3 | $3.53M | Sell |
72,168
-2,755
| -4% | -$160K | ﹤0.01% | 2955 |
|
|
2021
Q2 | $7.1M | Buy |
74,923
+65,213
| +672% | +$3.45M | ﹤0.01% | 2603 |
|
|
2021
Q1 | $307K | Buy |
9,710
+8,995
| +1,258% | +$329K | ﹤0.01% | 3975 |
|
|
2020
Q4 | $10K | Hold |
715
| – | – | ﹤0.01% | 4343 |
|
|
2020
Q3 | $26K | Hold |
715
| – | – | ﹤0.01% | 4179 |
|
|
2020
Q2 | $41K | Sell |
715
-120
| -14% | -$4.26K | ﹤0.01% | 4074 |
|
|
2020
Q1 | $17K | Hold |
835
| – | – | ﹤0.01% | 4102 |
|
|
2019
Q4 | $20K | Hold |
835
| – | – | ﹤0.01% | 4155 |
|
|
2019
Q3 | $25K | Buy |
+835
| New | +$26.4K | ﹤0.01% | 4138 |
|
|
2018
Q2 | – | Sell |
-172
| Closed | -$14K | – | 4303 |
|
|
2018
Q1 | $14K | Buy |
+172
| New | +$16K | ﹤0.01% | 4187 |
|
|
2016
Q3 | – | Sell |
-8
| Closed | -$6K | – | 4186 |
|
|
2016
Q2 | $6K | Hold |
8
| – | – | ﹤0.01% | 4181 |
|
|
2016
Q1 | $8K | Hold |
8
| – | – | ﹤0.01% | 4182 |
|
|
2015
Q4 | $7K | Hold |
8
| – | – | ﹤0.01% | 4218 |
|
|
2015
Q3 | $17K | Buy |
8
+2
| +33% | +$5.13K | ﹤0.01% | 4192 |
|
|
2015
Q2 | $17K | Sell |
6
-1
| -14% | -$3.99K | ﹤0.01% | 4149 |
|
|
2015
Q1 | $35K | Hold |
7
| – | – | ﹤0.01% | 4189 |
|
|
2014
Q4 | $28K | Hold |
7
| – | – | ﹤0.01% | 4159 |
|
|
2014
Q3 | $27K | Hold |
7
| – | – | ﹤0.01% | 4192 |
|
|
2014
Q2 | $33K | Hold |
7
| – | – | ﹤0.01% | 4145 |
|
|
2014
Q1 | $33K | Buy |
+7
| New | +$41.4K | ﹤0.01% | 4086 |
|
Other funds holding ATOS
VCM
VFT
Northern Trust's ATOS Position: Q1 2026 in Review
Northern Trust reduced its Atossa Therapeutics (ATOS) stake by 0.02% in Q1 2026, selling an estimated $19 and leaving 19,224 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #4106.
Northern Trust first reported a position in ATOS in Q1 2014 and has held it in 38 quarters since. The position peaked at $7.1M in Q2 2021. 33 funds tracked by Wall St. Rank hold ATOS as of Q1 2026.
- Northern Trust held 19,224 shares of Atossa Therapeutics worth $101K as of Q1 2026.
- Northern Trust sold 3 Atossa Therapeutics shares in Q1 2026, an estimated $19.
- Atossa Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4106 holding.
- Northern Trust first reported a position in Atossa Therapeutics in Q1 2014 and has held it in 38 quarters since.
- Northern Trust's Atossa Therapeutics position peaked at $7.1M in Q2 2021.
- 33 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.